论文部分内容阅读
卵巢癌是妇科常见的三大恶性肿瘤之一,由于卵巢癌早期症状隐匿,且缺乏可靠和具体的早期诊断方法,患者的5年生存率始终徘徊在30%~40%,死亡率高居妇科恶性肿瘤之首〔1-2〕。卵巢癌因其特异的基因型,而具有明显的转移、抗肿瘤药物、复发等特征,影响患者预后〔3-5〕。虽然近年来手术联合化疗方案的应用,使卵巢癌治疗效果有所提高,死亡率由原来的90%降至10%,但卵巢癌患者的预后却一直未
Ovarian cancer is one of the three most common malignant tumors in gynecology. Due to the early symptoms of ovarian cancer and the lack of reliable and specific early diagnosis, the 5-year survival rate of patients is always hovering between 30% and 40%, and the mortality rate is high in gynecological malignancy Tumor first 〔1-2〕. Ovarian cancer because of its specific genotype, which has obvious metastasis, anti-tumor drugs, recurrence and other characteristics, affecting the prognosis of patients 〔3-5〕. Although the application of surgery combined with chemotherapy in recent years, the treatment effect of ovarian cancer has increased, the mortality rate dropped from 90% to 10%, but the prognosis of patients with ovarian cancer has not yet